Life Sciences: Areas of Practice

Company Formation

  • Incorporation and organization
  • Employment, consulting, SAB arrangements, compensation and benefits
  • Facilities acquisition and leasing

Product Development and Commercialization

  • Patent prosecution, analysis and strategy
  • FDA regulatory strategy and compliance
  • Corporate partnering transactions, strategic alliances and joint ventures
  • Clinical trial agreements
  • Manufacture, supply and distribution agreements
  • Vendor and investigator contracting for product formulation, manufacture, study and commercialization
  • Government contracts, CRADAs, NIH Grants
  • Product trademarks, USAN applications

Financing

  • Angel investment and venture capital financing
  • Public and follow on offerings 
  • Private placements, PIPES, 144A transactions and highly structured convertible instruments, spin-outs and roll-ups
  • Tax and tax planning
  • Royalty monetization and buy-outs
  • Clinical trial project finance

Strategic Planning

  • Mergers and acquisitions
  • Staged acquisitions
  • Intellectual property licensing, defense and enforcement
  • Securities and commercial litigation
  • Product liability
  • Antitrust and competition

Leading the PIPEs Market

Cooley was ranked as the number one most active issuer counsel in the US PIPE market during 2012 by Sagient Research. Learn more.

Related Press Mentions


Request a free copy of the IPO Handbook. Available in two versions—Emerging Companies and Life Sciences Companies, this introduction to IPOs  addresses the questions most often asked by companies contemplating public offerings.

©2003-2013 Cooley LLP. All rights reserved.
COOLEY® and the COOLEY LLP® logo are registered U.S. service marks of Cooley LLP.
Cooley was founded in 1920 – for our story, visit our history page.